Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
申请人:Prosidion Limited
公开号:US08278442B2
公开(公告)日:2012-10-02
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.
BICYCLIC ARYL AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
申请人:Bloxham Jason
公开号:US20100173886A1
公开(公告)日:2010-07-08
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.